Table 3 Regression analysis

From: In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics

 

Relapse

No relapse

Regression coefficient

Odds ratio

P value

Local relapse

     

Oestrogen receptor α

     

 Positive

34

69

0.1132

1.12

0.787

 Negative

11

25

   

Progesterone receptor

     

 Positive

20

45

−0.138

0.87

0.705

 Negative

25

49

   

HER2

     

 Positive

13

27

0.008

1.008

0.984

 Negative

32

67

   

STS

     

 Positive

16

65

−1.367

0.255

<0.001

 Negative

28

29

   

17βHSD2

     

 Positive

41

72

1.429

4.176

0.027

 Negative

3

22

   

Androgen receptor

     

 Positive

40

77

0.955

2.59

0.149

 Negative

3

15

   

Glucocorticoid receptor

     

 Positive

23

45

0.346

1.413

0.365

 Negative

17

47

   

Aromatase

     

 Cont.

  

0.039

1.039

0.802

Oestrogen receptor β

     

 Cont.

  

−0.002

0.998

0.304

Ki67

     

 Cont.

  

−0.003

0.99

0.782

Distal relapse

     

Oestrogen receptor α

     

 Positive

29

72

−0.034

0.9667

0.938

 Negative

10

24

   

Progesterone receptor

     

 Positive

19

46

0.03209

1.032

0.932

 Negative

20

50

   

HER2

     

 Positive

13

25

0.3507

1.42

0.394

 Negative

25

71

   

STS

     

 Positive

11

68

−1.7852

0.168

<0.001

 Negative

27

28

   

17βHSD2

     

 Positive

35

74

1.244

3.468

0.055

 Negative

3

22

   

Androgen receptor

     

 Positive

34

81

0.598

1.819

0.374

 Negative

3

13

   

Glucocorticoid receptor

     

 Positive

21

45

0.5647

1.759

0.167

 Negative

13

49

   

Aromatase

     

 Cont.

  

−0.065

0.937

0.680

Oestrogen receptor β

     

 Cont.

  

−0.001

0.999

0.662

Ki67

     

 Cont.

  

0.00342

1.033

0.756

  1. Relationships between nuclear receptors, steroidogenic enzymes, and clinical outcome. Samples with a P value falling below 0.05 are given in italics